DekaBank Deutsche Girozentrale - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 166 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$178,000
-18.7%
49,6000.0%0.00%
-100.0%
Q2 2021$219,000
+31.1%
49,6000.0%0.00%0.0%
Q1 2021$167,000
-2.9%
49,6000.0%0.00%0.0%
Q4 2020$172,000
+55.0%
49,6000.0%0.00%
Q3 2020$111,000
+19.4%
49,600
-2.7%
0.00%
-100.0%
Q3 2019$93,000
-62.8%
51,000
-50.0%
0.00%0.0%
Q2 2019$250,000
+20.8%
102,000
+63.2%
0.00%0.0%
Q1 2019$207,000
+81.6%
62,500
+22.5%
0.00%0.0%
Q4 2018$114,000
-44.9%
51,000
-18.4%
0.00%0.0%
Q3 2018$207,000
+16.3%
62,5000.0%0.00%0.0%
Q2 2018$178,000
-23.3%
62,5000.0%0.00%
-50.0%
Q1 2018$232,000
+146.8%
62,500
+35.9%
0.00%
+100.0%
Q1 2016$94,000
-11.3%
46,000
-1.9%
0.00%0.0%
Q4 2014$106,000
+6.0%
46,900
-8.8%
0.00%0.0%
Q3 2014$100,000
-45.4%
51,400
+2.0%
0.00%
-66.7%
Q2 2014$183,000
-13.3%
50,400
-7.4%
0.00%0.0%
Q1 2014$211,000
+56.3%
54,400
+9.0%
0.00%
+50.0%
Q4 2013$135,000
-22.9%
49,900
+2.0%
0.00%
-33.3%
Q3 2013$175,00048,9000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CM Management, LLC 1,500,000$1,620,0001.72%
Soleus Capital Management, L.P. 14,803,015$15,987,2561.48%
ARMISTICE CAPITAL, LLC 17,136,000$18,506,8800.28%
SPHERA FUNDS MANAGEMENT LTD. 1,228,126$1,326,3760.24%
GSA CAPITAL PARTNERS LLP 971,441$1,0490.09%
NJ State Employees Deferred Compensation Plan 200,000$216,0000.03%
Providence Wealth Advisors, LLC 27,500$29,0130.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,151,765$1,243,9060.03%
XTX Topco Ltd 164,238$177,3770.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 3,369,076$3,638,6020.02%
View complete list of RIGEL PHARMACEUTICALS INC shareholders